Clinical Trials Directory

Trials / Completed

CompletedNCT05366491

IL-38 Evaluation as a Biomarker in Pediatric Asthma

Serum Human IL-38 Levels in Asthmatic Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
103 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
6 Years – 14 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate the associations between serum IL-38 levels and different variables of asthma in children such as laboratory variables, pulmonary function test results, the diagnosis of asthma, and in correlation with disease severity.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTIl-38 serum levelmeasurement of serum levels of IL-38

Timeline

Start date
2020-08-01
Primary completion
2021-01-12
Completion
2021-04-15
First posted
2022-05-09
Last updated
2022-05-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05366491. Inclusion in this directory is not an endorsement.

IL-38 Evaluation as a Biomarker in Pediatric Asthma (NCT05366491) · Clinical Trials Directory